Key facts
- This page summarizes Christine Chambers's Form 4 filing for PETMED EXPRESS INC (PETS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 14:00.
Christine Chambers - 31 May 2024 Form 4 Insider Report for PETMED EXPRESS INC (PETS)
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 14:00:16 UTC
- Prior SEC filing
- 20 May 2024
- Next SEC filing
- 28 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christine Chambers
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christine Chambers filed Form 4 for PETMED EXPRESS INC (PETS) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 20 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PETS
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -41,342
- Change %
- -39%
- Price
- $0.000000
- Shares after
- 65,146
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PETS
transaction
Derivative
Performance Share Units
Disposed to Issuer
- Transaction value
- $0
- Shares
- -8,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the forfeiture as a result of the Transition and Separation Agreement dated May 31, 2024 between the Company and the reporting person ("Agreement") of (i) 3,917 restricted stock units granted pursuant to the PetMed Express, Inc.'s 2022 Employee Equity Compensation Plan ("2022 Plan") on June 15, 2023, and (ii) 37,425 restricted stock units granted pursuant to the 2022 Plan on May 16, 2024.
Footnote F2
Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.
Footnote F3
Represents the forfeiture as a result of the Agreement of 8,000 performance stock units granted pursuant to the 2022 Plan on June 15, 2023.